Does TOFACITINIB Cause Bone density decreased? 156 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 156 reports of Bone density decreased have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
156
Reports of Bone density decreased with TOFACITINIB
0.1%
of all TOFACITINIB reports
16
Deaths
62
Hospitalizations
How Dangerous Is Bone density decreased From TOFACITINIB?
Of the 156 reports, 16 (10.3%) resulted in death, 62 (39.7%) required hospitalization, and 47 (30.1%) were considered life-threatening.
Is Bone density decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 156 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Bone density decreased?
EMTRICITABINE\TENOFOVIR DISOPROXIL (16,315)
TENOFOVIR DISOPROXIL (10,586)
EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (9,547)
COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (4,529)
EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (3,497)
TERIPARATIDE (1,178)
DENOSUMAB (968)
METHOTREXATE (599)
ADALIMUMAB (584)
TOCILIZUMAB (573)
Which TOFACITINIB Alternatives Have Lower Bone density decreased Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN